This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Michael Tanowitz, PhD
Associate Director, Medicinal Chemistry at Ionis Pharmaceuticals


Michael Tanowitz has spent the last 5 years at Ionis Pharmaceuticals developing receptor targeting strategies for the extrahepatic delivery of antisense oligonucleotides. Michael obtained a PhD in Molecular and Cellular Pharmacology from the University of Virginia, after which he conducted postdoctoral work at the University of California, San Francisco, which centered on the postendocytic membrane trafficking of G-protein coupled receptors. Prior to joining Ionis Michael led small molecule oncology discovery projects in the Department of Biochemical and Cellular Pharmacology at OSI Pharmaceuticals

Agenda Sessions

  • Chairperson’s Remarks

  • Targeted Delivery of Antisense Oligonucleotides to Select Tissues and Cells

  • Chairperson’s Remarks